GlassScriptPhysician profile
David H Clements
NPI 1932574118
$4,942.69
in general payments reported to CMS, 2019-2025
18 companies · $1,002 in 2025
The $1,002 reported for 2025 was more than what 81% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,781 · 2020: $215 · 2021: $140 · 2022: $400 · 2023: $642 · 2024: $761 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,405.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,753.28 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $895.52 | 2023-2025 | Caplyta |
| Abbvie INC. | $759.67 | 2021-2025 | Vraylar |
| Axsome Therapeutics, INC. | $462.33 | 2022-2025 | Auvelity |
| Allergan, INC. | $200.00 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $178.54 | 2019-2022 | |
| Lundbeck LLC | $168.29 | 2021-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $144.83 | 2022 | |
| Neurocrine Biosciences, INC. | $74.97 | 2023-2024 | Ingrezza |
| Collegium Pharmaceutical, INC. | $63.14 | 2025 | Jornay Pm |
| Corium, LLC | $48.06 | 2025 | Azstarys |
| Alkermes, INC. | $46.59 | 2025 | Aristada, Lybalvi |
| Noven Therapeutics, LLC | $43.13 | 2024 | Xelstrym |
| Supernus Pharmaceuticals, INC. | $30.55 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $28.88 | 2025 | Austedo Xr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $18.93 | 2025 | Brixadi |
| Otsuka America Pharmaceutical, INC. | $14.05 | 2023 | Rexulti |
| Bausch Health US, LLC | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.